Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Barbara Weber
AddedFeb 13, 2024
UpdatedMay 31, 2026
Barbara Weber

Barbara Weber

Board Member, Tango Therapeutics

CrunchbaseLinkedIn

Barbara Weber's Career

Tango Therapeutics
Tango Therapeutics

Boston, MA, US

Board Member· Board
Revolution Medicines
Revolution Medicines

Redwood City, CA, US

Board Member· Board
Fog Pharmaceuticals
Fog Pharmaceuticals

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Barbara Weber's Career

Tango Therapeutics
Tango Therapeutics
Public$351M1102017Boston, MA, US
Board Member· Board

Leadership at Tango Therapeutics

José BaselgaJosé BaselgaCo-Founder
Timothy LuTimothy LuCo-Founder
Cary PfefferCary PfefferBoard Member
William G. KaelinWilliam G. KaelinBoard Member
Alexis BorisyAlexis BorisyBoard Member
Antoni RibasAntoni RibasBoard Member

Similar to Tango Therapeutics

Marengo TherapeuticsMarengo TherapeuticsCambridge, MA, USCancer Treatmentest. 2015Marengo TherapeuticsCambridge, MA, US · est. 2015

Marengo Therapeutics: A clinical-stage biotech company dedicated to improving patient lives.

Series B · $80M36
GO TherapeuticsGO TherapeuticsCambridge, MA, USCancer Therapiesest. 2014GO TherapeuticsCambridge, MA, US · est. 2014

GO Therapeutics, Inc.: A US-based biotech firm specializing in cancer-specific immunotherapies and drugs.

Series A · $5M11
TG TherapeuticsTG TherapeuticsNew York City, NY, USCancer Treatments, Pharmaceuticalsest. 1993TG TherapeuticsNew York City, NY, US · est. 1993

TG Therapeutics: A biopharmaceutical firm innovating cancer treatments, focusing on non-Hodgkins lymphoma.

Public · $205M226
Window TherapeuticsWindow TherapeuticsBoston, MA, USCancer Treatmentest. 2021Window TherapeuticsBoston, MA, US · est. 2021

Window Therapeutics: A biotech firm innovating targeted cancer treatments for unmet patient needs.

Angel · $256k4
Revolution Medicines
Revolution Medicines
Public$1.1B2462014Redwood City, CA, US
Board Member· Board

Recent news

Reed Jobs would rather talk about curing cancer than his last nameTechCrunch · 2026

Leadership at Revolution Medicines

Liz McKee AndersonLiz McKee AndersonBoard Member
Martin BurkeMartin BurkeBoard Member
Eric T. SchmidtEric T. SchmidtBoard Member
Mark A. GoldsmithMark A. GoldsmithBoard Member
Kevan ShokatKevan ShokatBoard Member
Vincent A. MillerVincent A. MillerBoard Member
Fog Pharmaceuticals
Fog Pharmaceuticals
Series D$385.3M1472015Cambridge, MA, US
Board Member· Board

Leadership at Fog Pharmaceuticals

Corey GoodmanCorey GoodmanBoard Member
Rick KlausnerRick KlausnerBoard Member
Gregory L. VerdineGregory L. VerdineCo-Founder
Weiqing ZhouWeiqing ZhouCo-Founder
Edward FitzgeraldEdward FitzgeraldBoard Member
Jeffrey LeerinkJeffrey LeerinkBoard Member

Similar to Fog Pharmaceuticals

Foghorn TherapeuticsFoghorn TherapeuticsCambridge, MA, USDrug Development, Pharmaceuticalsest. 2015Foghorn TherapeuticsCambridge, MA, US · est. 2015

Foghorn Therapeutics Inc., a US-based pharmaceutical company, innovates novel drugs for cancer and serious disorders.

Public · $111M161
Camino PharmaCamino PharmaSan Diego, CA, USCancer Treatment, Drug Developmentest. 2014Camino PharmaSan Diego, CA, US · est. 2014

Camino Pharma: A tech startup pioneering first-in-class cancer and CNS disorder therapies.

Seed · $13.7M3
Frontier MedicinesFrontier MedicinesSouth San Francisco, CA, USPrecision Medicine, Therapeuticsest. 2018Frontier MedicinesSouth San Francisco, CA, US · est. 2018

Frontier Medicines, a US-based precision medicine firm, pioneers in developing treatments for previously undruggable diseases.

Series B · $244M128

Barbara Weber's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Barbara Weber

Daniella BeckmanDaniella BeckmanBoard Member · Blueprint MedicinesEric SiegfriedEric SiegfriedFounder & CEO · TangoPranav TyagiPranav TyagiFounder · Tango AnalyticsScott BeckScott BeckBoard Member · Pacific Dental ServicesDouglas J. BartekDouglas J. BartekCo-Founder · Tango Networks